guanabenz has been researched along with cardiovascular agents in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cohn, JN; Francis, GS | 1 |
| Cirule, H; Dambrova, M; Kalvinsh, I; Meirena, D; Veveris, M; Wikberg, JE | 1 |
1 review(s) available for guanabenz and cardiovascular agents
| Article | Year |
|---|---|
The autonomic nervous system in congestive heart failure.
Topics: Adrenergic beta-Antagonists; Alprazolam; Animals; Autonomic Nervous System; Benzodiazepines; Blood Vessels; Bromocriptine; Cardiovascular Agents; Catecholamines; Clonidine; Cricetinae; Dogs; Dopamine; Guanabenz; Heart; Heart Failure; Hemodynamics; Humans; Myocardium; Norepinephrine; Physical Exertion; Posture; Prognosis; Receptors, Adrenergic; Reflex; Stress, Physiological; Sympathetic Nervous System | 1986 |
1 other study(ies) available for guanabenz and cardiovascular agents
| Article | Year |
|---|---|
Cardioprotective effects of N-hydroxyguanidine PR5 in myocardial ischaemia and reperfusion in rats.
Topics: Animals; Antihypertensive Agents; Arrhythmias, Cardiac; Cardiovascular Agents; Dose-Response Relationship, Drug; Enzyme Inhibitors; Guanabenz; Guanidines; Hydroxylamines; Male; Malondialdehyde; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Oxidation-Reduction; Rats; Rats, Wistar; Reperfusion Injury; Xanthine Oxidase | 1999 |